Intravitreal bevacizumab for peripapillary classic subretinal neovascularization [2]

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 3, 2007, Pages 340-341

  Spandau, Ulrich H M ^a,b   Jonas, Jost B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Universitäats Augenklinik ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

AGED; CASE REPORT; CLINICAL FEATURE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LETTER; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA EDEMA; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; RETINAL NEOVASCULARIZATION; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 34248173011     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00832.x     Document Type: Letter

References (4)

1. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA & Guist MJ (2006): Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113: 363-332.
2. Rosenblatt BJ, Shah GK & Binder K (2005): Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization. Retina 25: 33-37.
3. Rosenfeld PJ, Moshfeghi AA & Puliafito CA (2005): Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36: 331-335.
4. Spandau UH, Ihloff A & Jonas JB (2006): Functional restitutio ad integrum by intravitreal bevacizumab for exudative age-related macular degeneration. Ophthalmic Res (in press).